一点「涂抹」就够了:使用大麻浓缩物后神经与心脏毒性病例报告
本文报告一例17岁运动男性使用大麻浓缩物「dabs」后出现严重躁动需镇静插管、收缩压峰值达190s mmHg、高热达102°F,并出现血清肌钙蛋白升高伴持续性心动过速,且无明确非中毒性病因。对患者家中「dabs」样本及全面尿液药物筛查行串联液相质谱(t-LCMS)确认。作者提出大麻浓缩物中THC浓度及THC:CBD比值升高可能通过拟交感与5-羟色胺能通路引起躁动和终末器官损伤。该病例首次报告「dabbing」相关心肌损伤,提示急诊/ICU应关注大麻浓缩物使用史及心脏毒性评估。
要点
- 17岁运动员使用大麻浓缩物「dabs」后出现严重躁动需镇静插管、收缩压峰值达190s mmHg、高热达102°F。
- 患者出现血清肌钙蛋白升高伴持续性心动过速,镇静后仍持续,且无明确非中毒性病因。
- 经家中「dabs」样本及全面尿液药物筛查行串联液相质谱(t-LCMS)确认。
- 作者提出大麻浓缩物中THC浓度及THC:CBD比值升高可能通过拟交感与5-羟色胺能通路致躁动和终末器官损伤。
- 本文首次报告「dabbing」相关心肌损伤,提示需将大麻浓缩物使用纳入急诊/ICU毒性评估。
适用人群与场景
- 17岁运动男性,使用大麻浓缩物「dabs」后出现中毒症状。
处置流程与药物剂量
- 因严重躁动需镇静并插管以保障安全。
红旗征与不能漏的情况
- 严重躁动需镇静插管以保障安全。
- 收缩压峰值达190s mmHg。
- 高热达102°F。
- 血清肌钙蛋白升高伴持续性心动过速,镇静后仍持续,且无明确非中毒性病因。
研究设计与关键结果
- 病例报告:17岁运动男性使用「dabs」后出现躁动需镇静插管、收缩压峰值190s mmHg、高热达102°F、血清肌钙蛋白升高伴持续性心动过速。
- 对患者家中「dabs」样本及全面尿液药物筛查行串联液相质谱(t-LCMS)确认。
- 作者提出大麻浓缩物中THC浓度及THC:CBD比值升高可能通过拟交感与5-羟色胺能通路引起躁动和终末器官损伤。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为大麻浓缩物中THC浓度及THC:CBD比值升高可能通过拟交感与5-羟色胺能通路引起躁动和终末器官损伤。
- 本文首次报告「dabbing」相关心肌损伤,提示急诊/ICU需关注大麻浓缩物使用史及心脏毒性评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: The use of marijuana and cannabis concentrates is increasing, especially following decriminalization in several states. Psychosis and cardiotoxicity have been reported following cannabis use; however, myocardial injury from "dabbing" has not yet been reported. We report a case of hyperthermia, tachycardia, hypertension, severe agitation, neuro-, and cardiotoxicity following the use of "dabs" where there is concomitant confirmatory biological and sample testing.
CASE DETAILS: A 17-year-old athletic man developed agitation requiring sedation and intubation for safety, with peak systolic blood pressures in the 190s and hyperthermia (to 102 °F). He developed elevated serum troponins with persistent tachycardia despite sedation and no clear non-intoxicant etiology. It was discovered that the patient had recently been "dabbing"; an exhaustive search of his home found a sample of the "dabs" which was analyzed along with a comprehensive urine drug screen by tandem liquid mass spectroscopy (t-LCMS) for confirmation.
DISCUSSION: Tetrahydrocannabinol (THC) has been increasingly associated with agitation and cardiotoxicity, while cannabidiol (CBD) has been associated with neuroprotective, inhibitory states. We propose that increasing concentrations of THC as well as THC:CBD ratios seen in cannabis concentrates such as "dabs" may cause agitation and end-organ damage through sympathomimetic and serotonergic pathways.
参考来源
- Rickner SS, Cao D, Kleinschmidt K, et al. A little "dab" will do ya' in: a case report of neuro-and cardiotoxicity following use of cannabis concentrates. Clin Toxicol (Phila). 2017. PMID: 28644052. doi:10.1080/15563650.2017.1334914
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。